9-72694619-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138691.3(TMC1):c.141T>A(p.Asp47Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,612,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_138691.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000586 AC: 89AN: 151932Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000140 AC: 35AN: 249926Hom.: 0 AF XY: 0.000141 AC XY: 19AN XY: 135082
GnomAD4 exome AF: 0.0000507 AC: 74AN: 1460882Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 726724
GnomAD4 genome AF: 0.000585 AC: 89AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74346
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Asp47Glu vari ant in TMC1 has not been previously reported in individuals with hearing loss. This variant has been identified in 0.2% (21/9910) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs140 388347). Computational prediction tools and conservation analyses suggest that t he Asp47Glu variant may not impact the protein, though this information is not p redictive enough to rule out pathogenicity. In summary, while the clinical sign ificance of the p.Asp47Glu variant is uncertain, these data suggest that it is m ore likely to be benign. -
Inborn genetic diseases Uncertain:1
The c.141T>A (p.D47E) alteration is located in exon 7 (coding exon 3) of the TMC1 gene. This alteration results from a T to A substitution at nucleotide position 141, causing the aspartic acid (D) at amino acid position 47 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at